Finance
S&P 500 7,707.69 -40.02 -0.52% Dow 53,319.68 -366.43 -0.68% Nasdaq 26,455.67 -128.39 -0.48% NYSE Composite 24,644.10 -76.05 -0.31% Russell 2000 2,969.21 +0.94 +0.03% VIX 14.25 -0.07 -0.49%

IBIO · iBio, Inc.

NYSE MKT LLC - Real Time Price • USD

iBio Inc (IBIO)

NYSE MKT LLC Biotechnology
Options chain →
$1.31 +0.01 (+1.15%)
● Market open
DAY'S RANGE $1.31
$1.28 $1.32
52-WEEK RANGE $1.31
$0.77 $3.82

What's happening

  • IBIO is up 1.15% today, trading at $1.31. — Live quote
  • Volume today (2,945) is well below its 3-month average of 896,420. (Finnhub fundamentals)
  • Last quarter's EPS beat estimates: $-0.06 actual vs. $-0.06 estimated (+6.1%). (Finnhub earnings history)

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$79.1M
P/E (TTM1)—
EPS2 (TTM)$-0.83
Div Yield—
Beta31.41
Volume2,945
Open1.29
Prev Close1.30
Bid / Ask1.31 / 1.32
Next Earnings 2026-11-10

Analyst Recommendations

Strong buy 4 Buy 9 Hold 1 Sell 0 Strong sell 0

Aggregate ratings for 2026-09-01 (14 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
IBIO -32.12%
vs S&P 500 -44.33%
1-YEAR RETURN
IBIO +52.54%
vs S&P 500 +33.68%
6-MONTH RETURN
IBIO -53.55%
3-MONTH RETURN
IBIO -25.57%

Valuation Measures & Ratios

Enterprise Value4$32.1M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)159.44
Price / Book70.85
EV4 / Revenue64.17
EV4 / EBITDA—
Profit Margin-3049.40%
Operating Margin-3113.60%
Return on Equity (ROE8)-53.86%
Return on Assets (ROA9)-46.48%
Avg Volume (3M)896,420
Quarterly history (5 periods)
Measure Mar '26Dec '25Sep '25Mar '25Dec '24
Market cap $246.1M $194.8M $41.7M $39.8M $21.4M
P/E -9.01 -8.14 -2.20 -2.43 -1.08
Price/Sales — 649.49 138.86 — —
Price/Book 3.17 3.44 0.74 3.50 1.54
EV/Revenue — 553.92 45.15 — —
ROE -35.21% -42.32% -33.79% -143.98% -142.04%
ROA -31.81% -37.17% -29.51% -85.78% -90.96%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short5,027,874
Change from Prior Settlement-1.52%
% of Float—
Days to Cover (Short Ratio)11.12

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

No accessible free API for these — links go to the source directly.

Morningstar Motley Fool MarketBeat

Financials

Income statement

Line item Mar '26Dec '25Sep '25Mar '25Dec '24Sep '24Mar '24Dec '23
Revenue — $0 $100.0K $0 $200.0K $0 — —
Gross profit — — — — — — — —
Operating income -$8.4M -$9.4M -$6.0M -$4.9M -$4.4M -$4.1M -$3.6M -$4.5M
Net income -$7.7M -$9.0M -$5.7M -$4.9M -$4.4M -$4.0M -$3.2M -$8.2M
EPS (diluted) $-0.06 $-0.09 $-0.11 $-0.49 $-0.48 $-0.46 $-0.85 $-4.42
EPS (basic) $-0.06 $-0.09 $-0.11 $-0.49 $-0.48 $-0.46 $-0.85 $-4.42

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $99.1M $85.8M $64.4M $64.2M $23.2M $19.1M $21.7M $24.5M
Total liabilities $13.4M $8.3M $7.8M $8.1M $8.3M $7.7M $7.8M $6.8M
Stockholders' equity $85.7M $77.5M $56.6M $56.0M $14.9M $11.4M $13.9M $17.8M
Total current assets $92.2M $77.3M $53.4M $50.8M $9.7M $6.1M $8.3M $11.7M
Total current liabilities $11.7M $6.5M $5.9M $6.0M $6.1M $5.4M $4.7M $3.5M
Cash & equivalents $56.4M $47.6M $28.7M $28.1M $8.6M $5.0M $7.0M $11.0M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$6.2M -$6.1M -$5.2M -$5.7M -$4.6M -$3.1M -$3.9M -$3.7M
Investing cash flow -$4.4M -$3.1M -$3.0M -$21.5M $45.0K -$14.0K -$2.0K $713.0K
Financing cash flow $19.4M $28.2M $8.8M $46.7M $8.2M $1.1M -$152.0K -$162.0K
Free cash flow -$6.2M -$6.1M -$5.8M -$5.7M -$4.6M -$3.1M -$3.9M -$3.7M
Capital expenditures $19.0K $11.0K $516.0K $32.0K $1.0K $14.0K $1.0K $0
Share-based compensation $420.0K $377.0K $253.0K $323.0K $270.0K $370.0K $475.0K $415.0K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding IBIO as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-01-10 to 2026-03-26

Recent transactions

  • Insiders have net bought 51,105 shares over the last 182 days, across 4 purchases and 0 sales.
  • Most recent: Banjak Marc (Chief Legal Officer) — Open market purchase of 12,500 shares on 2026-03-26.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)51,105 sh(4 txns)
Sales (open market)0 sh(0 txns)
Net Shares+51,105

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Banjak MarcChief Legal OfficerOpen market purchase2026-03-2612,500
Duran FelipeChief Financial OfficerOpen market purchase2026-03-1924,835
Brenner MartinSee RemarksOpen market purchase2026-03-1912,336
Arkowitz DavidDirectorOpen market purchase2025-01-1018,382
Clark William DDirectorOpen market purchase2025-01-101,838

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-03-26Banjak MarcChief Legal OfficerOpen market purchase 12,500$1.64
2026-03-26Banjak MarcChief Legal OfficerOpen market purchase 1,434$1.76
2026-03-19Duran FelipeChief Financial OfficerOpen market purchase 24,835$2.02
2026-03-19Brenner MartinSee RemarksOpen market purchase 12,336$2.02
2025-01-10Duran FelipeChief Financial OfficerOpen market purchase 9,191$2.72
2025-01-10Brenner MartinSee RemarksOpen market purchase 9,191$2.72
2025-01-10Banjak MarcChief Legal OfficerOpen market purchase 9,191$2.72
2025-01-10Arkowitz DavidDirectorOpen market purchase 18,382$2.72
2025-01-10Clark William DDirectorOpen market purchase 1,838$2.72

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-09-04 15:35 UTC

FiledFormReport periodOfficial filing
2026-08-2810-K2026-06-30 View on SEC.gov →
2026-08-288-K2026-08-28 View on SEC.gov →
2026-08-0442026-07-31 View on SEC.gov →
2026-08-048-K2026-07-31 View on SEC.gov →
2026-07-178-K2026-07-17 View on SEC.gov →
2026-07-018-K2026-07-01 View on SEC.gov →
2026-05-1942026-05-18 View on SEC.gov →
2026-05-1210-Q2026-03-31 View on SEC.gov →
2026-05-128-K2026-05-12 View on SEC.gov →
2026-05-088-K2026-05-07 View on SEC.gov →
2026-04-088-K2026-04-08 View on SEC.gov →
2026-03-2742026-03-26 View on SEC.gov →

Headlines about IBIO (iBio, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist